Chromatin, Inc. and Syngenta Biotechnology, Inc. Collaborate to Develop Gene Stacking Technology for Soybean

CHICAGO--(BUSINESS WIRE)-- Chromatin, Inc. announced today an extension of its research and commercial license agreement with Syngenta Biotechnology, Inc. for corn and soybeans for Chromatin’s proprietary gene stacking technology.

The agreement furthers a three-year relationship between the two companies. Under a 2007 agreement, Syngenta obtained non-exclusive rights to use Chromatin's gene stacking technology for trait genes in corn and soybeans, and in 2009, Syngenta obtained exclusive worldwide research and commercial license rights to that technology for use in sugar cane. Today, Chromatin announces that they have launched activities to further develop gene stacking technology for soybean applications.

Chromatin has developed a novel approach to gene stacking, using the plant's own DNA to deliver several genes on a mini-chromosome. These mini-chromosomes are genetic elements that are built to deliver multiple traits and accelerate the development of new products, providing benefits to growers, industrial bioprocessors, and consumers.

"Chromatin is pleased to expand its working relationship with Syngenta,” said Daphne Preuss, Chromatin’s CEO. “As a leading agribusiness company with a global commitment to developing and improving crops, Syngenta is an ideal partner. With their continued commitment to extend efforts to test and develop gene stacking technologies in corn, soybean, sugar cane and other crops, this collaboration with Syngenta allows us to further implement our mini-chromosome technology into applications that will make a difference in meeting global food, feed and fuel challenges.”

About Chromatin:

Chromatin, Inc. is a biotech company developing and marketing innovative technologies and products that benefit the agricultural, energy, chemical, nutritional, and pharmaceutical sectors. The company has successfully developed and commercialized its proprietary gene stacking technology, which can be used to simultaneously, and precisely introduce multiple genes in any plant. Chromatin is also deploying a broad and unique intellectual property platform to develop specialized sorghum feedstocks for the renewables industry, creating next generation, high-quality feedstocks to meet the precise yield and performance requirements of the bioprocessing industry. For additional information visit www.chromatininc.com.

About Syngenta:

Syngenta is one of the world's leading companies with more than 25,000 employees in over 90 countries dedicated to the purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.



CONTACT:

Chromatin, Inc.
Daphne Preuss, 312-235-3610
www.chromatininc.com

KEYWORDS:   United States  North America  Illinois

INDUSTRY KEYWORDS:   Health  Biotechnology  Genetics  Natural Resources  Agriculture  Research  Other Science  Science

MEDIA:

Logo
 Logo

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.